Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Semaglutide. | Image Credit: K KStock - stock.adobe.com

Semaglutide Linked to Lower Dementia Risk in Type 2 Diabetes

By Pearl Steinzor

June 24th 2025

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared with other diabetes drugs.

Type 2 diabetes - greenapple78 - stock.adobe.com

Previsit Tools Boost Diabetes Deprescribing in Older Adults, Study Finds

By Pearl Steinzor

June 23rd 2025

Diabetic man | Image credit: Krakenimages.com - stock.adobecom

Addressing Barriers to Hispanic Men's Engagement in Diabetes Prevention

By Pearl Steinzor

June 18th 2025

Liver disease | Image credit: Crystal light - stock.adobe.com

Fatty Liver Found in Half of Patients With Type 2 Diabetes, Study Finds

By Pearl Steinzor

June 13th 2025

DASH diet | Image credit: Albi - stock.adobe.com

DASH-Style Diet Lowers Blood Pressure in Type 2 Diabetes

By Pearl Steinzor

June 10th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

AJMC Peer Exchange geometric background

Continuing Medical Education

June 29th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology

June 29th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

October 5th 2015

Managing Repatha and Praluent Could Be a Walk in the Park for Health Plans

Thomas Morrow, MD

The PCSK9 drugs are stirring up a lot of attention, primarily around how to restrict access. But, no one is talking about how to best manage the patient's needs.

October 2nd 2015

Access to Palliative Care Remains an Issue in US Hospitals

Surabhi Dangi-Garimella, PhD

A study reports that despite the steady growth in hospital-based palliative care programs, access is sketchy and is driven by geographic location and hospital ownership.

October 2nd 2015

Technique Allows Scientists to Create Insulin-Producing Cells

Mary K. Caffrey

The technique deploys several strategies to reduce cancer risk. It is being evaluated in mouse models but researchers are already looking ahead to human studies.

October 1st 2015

Utah Providers: Too Much of Medicaid Tax Falls on Us

Mary K. Caffrey

An earlier plan from Governor Gary Herbert that was paid for with existing state funds was rejected by the legislature. The current plan would add 95,000 Utahns to Medicaid, with hospitals paying most of the state's share after 2017.

October 1st 2015

Severely Obese Children Face Higher Risk of Diabetes, Heart Disease, Study Finds

Researchers say the results may help physicians better target screening for obese youth.

September 30th 2015

Model Predicts Healthcare Utilization With EMR Information

Laura Joszt, MA

Researchers in China and the United States have developed a predictive model capable of forecasting which patients will account for either small or large proportions of healthcare resource utilization in the next 6 months.

September 30th 2015

Type 2 Diabetes Remission More Likely After Gastric Bypass, Sleeve Than Banding, Study Finds

Mary K. Caffrey

All 3 methods caused patients to lose weight, but 2 were more likely to produce remission in type 2 diabetes.

September 30th 2015

Conflict of Interest Rampant in Academic-Industry Partnerships

Surabhi Dangi-Garimella, PhD

A study published in BMJ measured the prevalence, annual compensation, and beneficial stock ownership of directors from publicly traded healthcare companies who had academic affiliations.

September 30th 2015

A Randomized Controlled Trial of Negative Co-Payments: The CHORD Trial

Kevin G. Volpp, MD, PhD Andrea B. Troxel, ScD Judith A. Long, MD Said A. Ibrahim, MD, MPH Dina Appleby, MS J. Otis Smith, EdD Jalpa A. Doshi, PhD Jane Jaskowiak, BSN, RN Marie Helweg-Larsen, PhD Stephen E. Kimmel, MD, MSCE

This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.

September 30th 2015

A Randomized Controlled Trial of Co-Payment Elimination: The CHORD Trial

Kevin G. Volpp, MD, PhD Andrea B. Troxel, ScD Judith A. Long, MD Said A. Ibrahim, MD, MPH Dina Appleby, MS J. Otis Smith, EdD Jane Jaskowiak, BSN, RN Marie Helweg-Larsen, PhD Jalpa A. Doshi, PhD Stephen E. Kimmel, MD, MSCE

This study tests the impact on blood pressure control of a reward that lowered co-payments for blood pressure medication to $0.

September 29th 2015

Lixisenatide New Drug Application Accepted for Review With CV Results Already in Hand

Mary K. Caffrey

Results presented at the American Diabetes Association in June showed no CV risk or benefit and no risk of pancreatic injury, an issue that has been of particular concern to FDA.

September 28th 2015

Behavioral Health at Heart of Recommended Medicaid Measures From National Quality Forum

Mary K. Caffrey

The recommendations for improving quality care in Medicaid track recent trends in psychiatric and diabetes care, which recognize the connection between physical and mental health.

September 28th 2015

Medtronic Announces US Availability of MiniMed Connect Technology

Mary K. Caffrey

The technology was approved by FDA in June and unveiled at the Scientific Sessions of the American Diabetes Association.

September 28th 2015

Diabetes: The Next Healthcare Tsunami

Eighty-six million US adults are at high risk of developing type 2 diabetes. Without prevention, there will be a drastic increase in the number of Americans who will develop type 2 diabetes.

September 25th 2015

Dexcom G5 Mobile CGM System Approved by FDA

Mary K. Caffrey

September 25th 2015

Synjardy Joins Ranks of Combo Therapies for T2DM

Mary K. Caffrey

September 25th 2015

Outlook Changing in Payer Coverage for Obesity Medications, Commentators Say

Many hoped the 2013 declaration by the American Medical Association that obesity is a disease would open the door for payer coverage of pharmacotherapy to treat it. While that did not happen right way, a new commentary in Evidence-Based Diabetes Management by Ted Kyle, RPh, MBA, and Fatima Cody Stanford, MD, MPH, MPA, outlines how the tide appears to be turning for coverage of evidence-based treatment.

September 25th 2015

Joslin Diabetes Center Taps Amenta as New President & CEO

Mary K. Caffrey

Peter S. Amenta, MD, PhD, spent 8 years as the dean of Rutgers Robert Wood Johnson Medical School during a period of tremendous growth and change.

September 24th 2015

Empagliflozin Is First Diabetes Drug to Hit "Holy Grail" of Cutting Heart Attack, Stroke Deaths in Clinical Trial

Mary K. Caffrey

September 24th 2015

Blood Pressure Medication at Night Lowers Diabetes Risk, Studies Say

Mary K. Caffrey

The research by the group from Spain is the latest effort to link sleep patterns, or disruption of sleep, to the development of type 2 diabetes.

September 23rd 2015

Fingernail Tests May Offer Cheap, Simple Way to Diagnose Diabetes

Mary K. Caffrey

Fingernail tests could offer a solution to diabetes testing in the developing world, and a faster test for gestational diabetes could diagnose this condition earlier in pregnancy.

September 23rd 2015

Dissecting the Patient Perception of FDA's Breakthrough Designation

Surabhi Dangi-Garimella, PhD

A JAMA Internal Medicine study found the terms "breakthrough" and "promising" raised people's expectations on the drug's performance as opposed to when the drugs were described as having met the breakthrough criteria.

September 23rd 2015

Survey Finds Young Patients With Diabetes Getting Fewer Eye Exams Than Older Patients

Mary K. Caffrey

Younger patients and those newly diagnosed were more likely to not receive eye exams than older persons with diabetes.

September 23rd 2015

Type 2 Diabetes Patients Should Be Screened for Liver Disease, Study Suggests

Mary K. Caffrey

Screening in a primary care setting may help managed care plans avoid long-term costs of complications of type 2 diabetes.

September 23rd 2015

Clinton Seeks Cap on Drug Expenses, Would Let Medicare Negotiate

Mary K. Caffrey

Hillary Clinton unveiled a plan in Iowa that features a $250 per month cap on drug costs for patients with chronic conditions. This comes 2 weeks after her chief rival for the Democratic nomination, US Senator Bernie Sanders of Vermont, introduced a bill aimed at reining in drug costs. In the summer, The American Journal of Managed Care said polling showed that rising drug costs were poised to become a major issue in the 2016 campaign.

September 23rd 2015

Physicians Believe in Biosimilars but Lack Awareness, Says Report by Quantia

Surabhi Dangi-Garimella, PhD

A white paper released by QuantiaMD has identified a lack of awareness and education about biosimilars among prescribing physicians.

September 22nd 2015

Intarcia Says Phase 3 Results Show Better Control Than Januvia for Type 2 Diabetes Mellitus

Mary K. Caffrey

The matchstick-like delivery system has been seen as game-changer in overcoming poor adherence. Filing for FDA approval is anticipated in early 2016.

September 22nd 2015

JAMA: High-Dose Liraglutide Causes Significant Weight Loss in Overweight Persons With T2DM

Mary K. Caffrey

The study showed an average weight loss of 6%, and weight loss of 10% for a quarter of the patients. Average BMI was 37.

September 22nd 2015

Research Describes "Dimmer Switch" in Pancreatic Islet Cells

The research could hold the key to a novel treatment for type 2 diabetes, although it will take years to adapt the idea to clinical practice.

September 21st 2015

Does Passive Smoking Boost Diabetes Risk? A Lancet Meta-analysis Says Yes

Mary K. Caffrey

Researcher found that not only was passive smoking associated with increased risk of type 2 diabete, but there was a direct dose-response relationship.

...

68 69 70 71 72 73 74 75 76

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions